The Clinton Health Access Initiative (CHAI) has teamed up with UNITAID and the UK’s Department of International Development (DFID) to negotiate new price reductions on key antiretroviral (ARV) drug regimens. Today’s announcement means HIV/AIDS treatment will be more widely available as the newly reduced price ceilings will be available to most of the 70 countries […]
Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, is arguably the U.S. government’s best-known scientist. John Donnelly interviewed Dr. Fauci for Science Speaks’ series on the 30th anniversary since the discovery of a virus that would turn out to be HIV, and he talked about everything from how he first learned of the disease, to his surprise in President George W. Bush’s commitment, to the unmet needs today to fight the pandemic. Read more…
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]